Pneuma Respiratory
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
870 State Farm Rd Ste 103B, Boone, North...Phone Number
(828) 434-6433Website
www.pneumarespiratory.comRevenue
$6.7 MillionIndustry
About Pneuma Respiratory
Pneuma Respiratory Org Chart
Is Pneuma Respiratory your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Pneuma Respiratory has new funding data
Congratulate Masked Content for being promoted to Masked Content at Pneuma Respiratory
Pneuma Respiratory, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Pneuma Respiratory has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Pneuma Respiratory had a recent Job posting/layoffs
Product Launch: Get notified when Pneuma Respiratory launches new products
Check out if Pneuma Respiratory is spiking on competitors!
Earning: See what the market has to say on Pneuma Respiratory recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Pneuma Respiratory
Compare insights from companies similar to Pneuma Respiratory, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pneuma Respiratory is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pneuma Respiratory is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pneuma Respiratory.
Pneuma Respiratory financials insights
Gather financial insights about Pneuma Respiratory, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$8.3M
Unspecified
$10M
Debt
$350K
Stock/Share Issuance
$3.6M
Pneuma Respiratory Tech Stack
A closer look at the technologies used by Pneuma Respiratory
Most Recent Scoops
Pneuma Respiratory News & Media
Pneuma Respiratory Advances Inhaled Therapeutics to Improve Respiratory Health
BOONE, N.C.--(BUSINESS WIRE)--Pneuma Respiratory, a med-tech and pharmaceutical company dedicated to advancing inhaled respiratory therapeutics, is introducing new transformational approaches to respiratory health to improve the standard of care for millions of patients worldwide. Focusing on treatments for smoking-related lung conditions, Pneuma has developed a novel aerosol generation technology that provides a more efficient way to deliver medication to the lungs. Pneuma is accelerating itsPneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products
BOONE, N.C.--(BUSINESS WIRE)--Pneuma Respiratory, a med-tech pharmaceutical company focused on the advancement of inhaled respiratory therapeutics, has created a new technology platform capable of delivering nonheated, water-based aerosols composed of droplets with diameters less than 1/100,000th of an inch. Nonheated delivery of nicotine requires aerosols with extremely small droplet sizes. Pneuma’s platform will, for the first time, provide a means to use nonheated aerosols for inhaled nicotiPneuma Respiratory Shares Improvements to Digital Soft Mist Inhaler at J.P Morgan Healthcare Conference
SAN FRANCISCO--(BUSINESS WIRE)--Pneuma Respiratory, a healthcare company focused on the advancement of inhaled respiratory therapeutics, is attending this week’s 41st Annual J.P. Morgan Healthcare Conference in San Francisco to unveil the latest iteration of its fully digital soft mist inhaler. First introduced in 2018, Pneuma Respiratory’s soft mist technology uses electronic breath actuation to simplify usage and improve delivery efficiency. The digital component delivers high dose confidencePneuma Respiratory, Inc. Announces New Chairman of the Board
BOONE, N.C., Aug. 21, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pneuma Respiratory
Pneuma Respiratory is at the forefront of precision aerosol technology, specializing in sub-micron droplet delivery for pharmaceuticals and reduced-risk nicotine solutions. Their innovative platform enables precise pulmonary delivery, enhancing therapeutic outcomes while minimizing systemic exposure, particularly for conditions such as asthma, COPD... Read More